Grace Therapeutics, Inc.
GRCE
$3.00
-$0.13-4.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.13M | 11.06M | 15.17M | 19.41M | 23.01M |
| Total Receivables | 126.00K | 301.00K | 415.00K | 398.00K | 722.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 453.00K | 583.00K | 477.00K | 622.00K | 283.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 22.71M | 11.94M | 16.06M | 20.43M | 24.01M |
|
|
|||||
| Total Current Assets | 22.71M | 11.94M | 16.06M | 20.43M | 24.01M |
| Net Property, Plant & Equipment | 2.00K | 19.00K | 21.00K | 23.00K | 5.00K |
| Long-term Investments | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M |
| Goodwill | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M |
| Total Other Intangibles | 41.14M | 41.13M | 41.13M | 41.13M | 41.15M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 71.99M | 61.22M | 65.35M | 69.72M | 73.30M |
|
|
|||||
| Total Accounts Payable | 601.00K | 665.00K | 1.68M | 1.55M | 1.01M |
| Total Accrued Expenses | 1.33M | 1.31M | 999.00K | 1.05M | 677.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.93M | 1.97M | 2.67M | 2.60M | 1.68M |
|
|
|||||
| Total Current Liabilities | 1.93M | 1.97M | 2.67M | 2.60M | 1.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.45M | 7.11M | 6.54M | 7.75M | 9.87M |
| Total Liabilities | 5.38M | 9.09M | 9.22M | 10.35M | 11.56M |
|
|
|||||
| Common Stock & APIC | 293.34M | 279.50M | 279.34M | 279.14M | 278.90M |
| Retained Earnings | -220.69M | -221.32M | -217.17M | -213.74M | -211.12M |
| Treasury Stock & Other | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M |
| Total Common Equity | 66.61M | 52.14M | 56.13M | 59.36M | 61.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 66.61M | 52.14M | 56.13M | 59.36M | 61.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 66.61M | 52.14M | 56.13M | 59.36M | 61.74M |
|
|
|||||